BrunoSan Finance Intelligence · April 01, 2026
Finance Intelligence News
Every article includes an Intel Score breakdown — so you know exactly how strong each signal is and where it came from. Not editorial judgment. Signal mathematics.
🏦 RATE DECISION
1.000
Gold's Three-Day Gain Signals Market Pivot from Geopolitical Risk to Fed Rate Path
Gold extended its three-day gain to $2,450/oz as signals of a potential end to the Iran conflict caused traders to shift focus from geopolitical risk to the rising probability of an economic downturn, pulling forward expectations for Fed rate cuts now reflected in a 15 bps drop in the December 2026 Fed Funds futures contract.
🏦 RATE DECISION
1.000
Why $4 Per Gallon Gasoline Is a Disinflationary Signal for the Federal Reserve
Rising gasoline prices function as a direct tax on U.S. consumers, suppressing discretionary demand and slowing the economy. The Federal Reserve will look past the temporary headline inflation spike and focus on this underlying weakness, increasing the probability of rate cuts from the current 4.38% federal funds target rate.
🚀 IPO
1.000
Geopolitical Risk Fails to Dent MTT Shipping's April IPO Plans
Malaysia's MTT Shipping and Logistics Bhd. is proceeding with its Initial Public Offering in April 2026, signaling confidence that steady cargo volumes will override investor concerns from ongoing Middle East conflict-related shipping disruptions.
📊 EARNINGS
1.000
UK Submarine Command Shake-up Follows Chinese Espionage Probe
A senior UK Royal Navy submarine captain has stepped down following an investigation into potential blackmail risk from a Chinese spy, signaling heightened counter-intelligence threats for critical defense assets and their supply chains.
📊 EARNINGS
1.000
Eli Lilly Bets $6.3B on Narcolepsy Drug, Acquiring Centessa to Diversify Beyond GLP-1 Dominance
Eli Lilly will acquire Centessa Pharmaceuticals for $6.3 billion to secure its midstage narcolepsy drug, a strategic deployment of capital to diversify its pipeline beyond its blockbuster GLP-1 franchise and enter the high-margin sleep disorder market.